Brief: Arocell Announces Takeover Offer For IDL Biotech

IDL Diagnostics AB (publ)

10/05/2021 07:11

May 10 (Reuters) - AroCell AB (publ)  AROC.ST :
    * MAKES PUBLIC TAKEOVER OFFER TO SHAREHOLDERS IN  IDL
BIOTECH AB
(PUBL)
    * OFFERS 0.63 AROCELL-SHARES FOR EACH SHARE IN IDL
    * OFFERS VALUES IDL SHARE AT ABOUT SEK 3.75 AND TOTAL NUMBER
OF
SHARES IN IDL AT ABOUT SEK 236.8 MILLION
    * OFFER REPRESENTS PREMIUM OF 56% IN REGARD TO CLOSING PRICE
OF
SEK 5.96 FOR AROCELL SHARE AND SEK 2.41 FOR IDL SHARE ON MAY 7
    * SYNERGY SAVINGS ESTIMATED IN TOTAL TO BE OF SEK 8 - 11
MILLION
PER YEAR INITIALLY
    * IN TOTAL, AROCELL SEES DIRECT SAVINGS WITHIN MANUFACTURING
AND
LOGISTICS OF SEK 2-3 MILLION PER YEAR INITIALLY
    * ISSUE OF NEW SHARES TO COMPRISE ABOUT 39.7 MILLION SHARES
IN CO,
CORRESPONDING TO 34.4% OF SHARES POST THE ISSUE

Source text for Eikon:  ID:nMFN7HWXY7 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))